Sitemap - 2022 - Healthtech Pigeon 🐦

#124: SPACs down, but not out πŸ₯Š

#123: The future of medical diagnostics? πŸ”Ž

#122 - Is healthtech recession-proof? πŸ“‰

#121: WHOOP, there it is πŸ”Š

#120: The inappropriate joke robot πŸ€–

#119: $7 short of an $8 blue tick

#118: A healthtech Bond villain πŸ•΅οΈ

#117: Pumpkin-spiced pathways πŸ§‹

#116: The return of Theranos? 🩸

#115: Spicy goggles = less drugs 🌢

#114: Aussies, AI & a worrying trend πŸ‡¦πŸ‡Ί

#113: Healthtech users’ biggest turnoffs πŸ‘‹

#112: Sailing the high(er) SEIS 🌊

#111: Stuck in limbo

#110: Arms race πŸ’ͺ

#109: Truss in the process

#108: The Biotech Bee Gees πŸ•Ί

#107: You are not a gorilla 🦍

#106: Soonicorn yoghurt 🍯

#105: Benchmarks, biotech & big bangs

#104: Rise of the chatbots πŸ’¬

#103: The end of Googling symptoms?🚦

#102: Part-man, part-building 🏒

#101: Two sides to every correction πŸͺ™

#100: Healthtech 1 - 0 Fintech 🌱

#99: Centaurs & Unicorns πŸ¦„

#98: Raise, Sell, Sleep. Repeat β™½

#97: Are you a good investment? πŸ“ˆ

#96: Netflix & No Chill 🍿

#95: Controlling the horse 🐴

#94 - Raises, Cutbacks, & Alan

#93 - The MySpace of European VC Valuations

#92 - Elizabeth Holmes under the hammer πŸ§‘β€βš–οΈ

#91: Seeds, bubbles, & unicorns

#90: Controlled Chaos?

#89: Biotech's Back, Baby.

#88: The worst Medtech/Fintech crossover yet?

#87: $6bn disappointment, Dolly Parton & Sly Stallone

#86: How can (A)I live without you? 🎀

#85: Healthtech without borders

#84: Cuddly AI 🧸

#83: Sandra Bullock & February's Hottest Seeds 🌱

#82: Is remote care leaving non-English speakers behind? πŸ”‡

#81: We stand with Ukraine πŸ‡ΊπŸ‡¦

#80: Drop it like it's hotπŸ”₯

#79 - Move fast and heal things ⏩

#78 - What does (a) good (merger) look like? πŸ™

#77: $30M down the loo? 🚽

#76: Stricken Swedish Snow Shoveler Saved By Decisive Drone

#75: Putting the fun into non-fungible tokens

#74: Tried to make me go to (tele)rehab πŸ“²

#73: New Year, Same Ol' PigeonπŸ‘Œ